1. Oh SJ, Eslami N, Nishihira T, Sarala PK, Kuba T, Elmore RS, et al. Electrophysiological and clinical correlation in myasthenia gravis. Ann Neurol. 1982. 12:348–354.
Article
2. Goli SK, Claussen GC, Oh SJ. Repetitive nerve stimulation test in myasthenic crisis. Neurology. 2009. 72:Suppl 3. A128.
3. Oh SJ, Kurokawa K, Claussen GC, Ryan HF Jr. Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome. Muscle Nerve. 2005. 32:515–520.
Article
4. Titulaer MJ, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms. Ann N Y Acad Sci. 2008. 1132:129–134.
5. Fujita J, Yamadori I, Yamaji Y, Yamagishi Y, Takigawa K, Takahara J. Myasthenia gravis associated with small-cell carcinoma of the lung. Chest. 1994. 105:624–625.
Article
6. Hazard PB, Bertorini TE, Griffin JP. Myasthenia gravis associated with small cell carcinoma of the lung. J Tenn Med Assoc. 1986. 79:273–276.
7. Miyoshi R, Yamaji Y, Shima S, Fujita J, Okada H, Takahara J. [A case of small cell lung cancer that developed during therapy for myasthenia gravis]. Nihon Kyobu Shikkan Gakkai Zasshi. 1995. 33:456–462.
8. Lennon VA. Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton syndrome. Neurology. 1997. 48:S23–S27.